SciSparc Ltd.

NasdaqCM:SPRC Stock Report

Market Cap: US$2.8m

SciSparc Management

Management criteria checks 4/4

SciSparc's CEO is Oz Adler, appointed in Apr 2018, has a tenure of 8.08 years. total yearly compensation is $396.00K, comprised of 68.7% salary and 31.3% bonuses, including company stock and options. directly owns 0.39% of the company’s shares, worth $11.10K. The average tenure of the management team and the board of directors is 8.1 years and 9.9 years respectively.

Key information

Oz Adler

Chief executive officer

US$396.0k

Total compensation

CEO salary percentage68.69%
CEO tenure8.1yrs
CEO ownership0.4%
Management average tenure8.1yrs
Board average tenure9.9yrs

Recent management updates

Recent updates

Seeking Alpha • Aug 15

SciSparc to acquire an American food supplements and cosmetics brand in ~$20M deal

A specialty clinical-stage pharmaceutical company SciSparc (NASDAQ:SPRC) signed a letter of intent with Merhavit M.R.M Holding and Management to acquire from it its rights to purchase, a top-seller Amazon.com account and American food supplements and cosmetics brand and trademark (Brand). The Brand offers dozens of GMP (Good Manufacturing Practice) manufactured hemp-based, U.S. made, top-ranked products, including various food supplements for different purposes and cosmetics. Company will pay a base payment of $4.59M upon closing of the transaction and an additional deferred cash payment of up to $1.1M that will be based on a multiple of 12 months EBITDA of the acquired Brand. “Our decision to enter this LOI is part of a previous board of directors decision to search for strategic transactions in high growth, high potential markets. We believe that acquiring a profitable top-seller brand with millions of dollars in annual sales, combined with our knowledge and expertise, can provide value to our shareholders. This potential transaction will expand our access to manufacturing and distribution channels, which aligns with our intention to market CannaMideTM, our PEA- based food supplement.“ commented Oz Adler, CEO.
Seeking Alpha • Jul 06

SciSparc board of directors to promote buyback program of up to $1M

SciSparc (NASDAQ:SPRC) authorized the company to take actions to implement a $1M buyback program for the company’s ordinary shares. The company expects to formally approve the buyback in conjunction with the approval of its financial statements for the 6 months ended June 30, 2022, together with a financial advisor’s opinion to be obtained.
Seeking Alpha • Jun 29

SciSparc completes development of SCI-110 to treat tourette syndrome

SciSparc (NASDAQ:SPRC) said on Wednesday it completed the development of its drug candidate, SCI-110, for Phase IIb study to treat tourette syndrome. SCI-110 is developed and manufactured by Procaps Group S.A. Tourette syndrome is a movement and neurobehavioral disorder characterized by chronic motor and vocal tics. The main goal of the study is to assess tic severity change as a continuous endpoint at week 12 and week 26.

CEO Compensation Analysis

How has Oz Adler's remuneration changed compared to SciSparc's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025US$396kUS$272k

-US$12m

Sep 30 2025n/an/a

-US$6m

Jun 30 2025n/an/a

-US$6m

Mar 31 2025n/an/a

-US$9m

Dec 31 2024US$453kUS$374k

-US$6m

Sep 30 2024n/an/a

-US$2m

Jun 30 2024n/an/a

-US$3m

Mar 31 2024n/an/a

-US$5m

Dec 31 2023US$379kUS$315k

-US$5m

Sep 30 2023n/an/a

-US$2m

Jun 30 2023n/an/a

US$287k

Mar 31 2023n/an/a

-US$1m

Dec 31 2022US$549kUS$358k

-US$3m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$9m

Mar 31 2022n/an/a

-US$7m

Dec 31 2021US$297kUS$223k

-US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$3m

Dec 31 2020US$301kUS$188k

-US$3m

Sep 30 2020n/an/a

-US$4m

Jun 30 2020n/an/a

-US$5m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019US$258kUS$189k

-US$5m

Compensation vs Market: Oz's total compensation ($USD396.00K) is below average for companies of similar size in the US market ($USD625.54K).

Compensation vs Earnings: Oz's compensation has been consistent with company performance over the past year.

CEO

Oz Adler (38 yo)

8.1yrs
Tenure
US$396,000
Compensation

Mr. Oz Adler, CPA, is Chairman of Fort Technology Inc. from September 15, 2025. Mr. Adler is CEO of Neurothera Labs Inc. He is Independent External Director of Rail Vision Ltd since June 2022. He is Direct...

Leadership Team

NamePositionTenureCompensationOwnership
Oz Adler
CEO & CFO8.1yrsUS$396.00k0.39%
$ 11.1k
Amitai Weiss
President & Directorless than a yearUS$245.00k1.96%
$ 55.5k
Adi Zuloff-Shani
Chief Technologies Officer10.3yrsUS$320.00k0.14%
$ 3.9k
8.1yrs
Average Tenure
58yo
Average Age

Experienced Management: SPRC's management team is seasoned and experienced (8.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Amitai Weiss
President & Director5.8yrsUS$245.00k1.96%
$ 55.5k
Itschak Shrem
Chairman of the Board5.8yrsUS$245.00k1.96%
$ 55.5k
Daniele Piomelli
Member of Scientific Advisory Boardno datano datano data
Elon Eisenberg
Member of Scientific Advisory Boardno datano datano data
James Leckman
Member of Scientific Advisory Board9.9yrsno datano data
Joseph Tam
Member of Scientific Advisory Boardno datano datano data
Kirsten Muller Vahl
Member of Scientific Advisory Board9.9yrsno datano data
Michael Davidson
Member of Scientific Advisory Board9.9yrsno datano data
Michael Bloch
Member of Scientific Advisory Board9.9yrsno datano data
Mellar Davis
Member of Scientific Advisory Boardno datano datano data
Saoirse O'Sullivan
Member of Scientific Advisory Boardno datano datano data
Amnon Shay
Independent Director5.3yrsno data0.65%
$ 18.3k
9.9yrs
Average Tenure
65yo
Average Age

Experienced Board: SPRC's board of directors are considered experienced (9.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/14 12:21
End of Day Share Price 2026/05/14 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SciSparc Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nathan WeinsteinAegis Capital Corporation
Piriyapon KongvanichBualuang Securities PCL
Maxim JacobsEdison Investment Research